By comparing MT1G expression levels in ccRCC tumor samples and normal kidney samples, it was found that MT1G was significantly downregulated in tumor tissues (p < 0.01) (Figure 3(a)). The gene discussed is MT1G; the disease is nonpapillary renal cell carcinoma.